glp-1 is what Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity The GLP-1 revolution: What UAB

4 Potential emerging biomarkers of early atherosclerotic initiation Building on these established biomarkers, emerging molecular regulators such as circulating microRNAs (miRs) have gained increasing attention as early indicators of atherosclerotic initiation

doi: 10.1016/j.fct.2011.07.007 242

van der Heide A, Meinders MJ, Speckens AEM, Peerbolte TF, Bloem BR, Helmich RC

Inhibitors of the sodium-glucose cotransporter 2 (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) have been studied and trialled in type 2 diabetes with an overwhelming body of evidence supporting their use in type 2 diabetes [10]

J.CoindreJ